Letter in response to Rivastigmine for the treatment of anticholinergic delirium following severe procyclidine intoxication

Adrienne R. Hughesa Department of Emergency Medicine, Oregon Health and Science University, Portland, Oregon, USA;b Oregon Poison Center, Portland, Oregon, USACorrespondence[email protected]

Kerry K. Moorec Department of Pharmacy, Oregon Health and Science University, Portland, Oregon, USA

Nathan D. Mahc Department of Pharmacy, Oregon Health and Science University, Portland, Oregon, USA

Asha R. Birminghamc Department of Pharmacy, Oregon Health and Science University, Portland, Oregon, USA

Roger K. Clark Jr.c Department of Pharmacy, Oregon Health and Science University, Portland, Oregon, USA

John A. Thompsona Department of Emergency Medicine, Oregon Health and Science University, Portland, Oregon, USA;b Oregon Poison Center, Portland, Oregon, USA

Robert G. Hendricksona Department of Emergency Medicine, Oregon Health and Science University, Portland, Oregon, USA;b Oregon Poison Center, Portland, Oregon, USA

show all

References

Van Kernebeek MW, Ghesquiere M, Vanderbruggen N, et al. Rivastigmine for the treatment of anticholinergic delirium following severe procyclidine intoxication. Clin Toxicol. 2020. DOI:10.1080/15563650.2020.1818768
Web of Science ®Google Scholar
Cozanitis DA. Galanthamine hydrobromide, a longer acting anticholinesterase drug, in the treatment of the central effects of scopolamine (hyoscine). Anaesthesist. 1977;26(12):649–650.
PubMed Web of Science ®Google Scholar
Aysın NM. Donepezil for anticholinergic drug intoxication: a case report. Prog Neuropsychopharmacol Biol Psychiatry. 2003;27:885–887.
PubMed Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Letter in response to Rivastigmine for the treatment of anticholinergic delirium following severe procyclidine intoxication

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Letter in response to Rivastigmine for the treatment of anticholinergic delirium following severe procyclidine intoxication

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date